Posted On: 09/16/2016 9:26:06 AM
Post# of 6891
$RGBP "Because dCellVax is a personalized cell therapy product aimed at activating the immune system of patients with metastatic breast cancer, we are excited to potentially have a product to deliver to patients who at the moment have no other options," said Dr. David Koos, CEO of Regen BioPharma.
https://finance.yahoo.com/news/regen-biopharm...00789.html
https://finance.yahoo.com/news/regen-biopharm...00789.html
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼
